Adaptilens
PrivateLast Round
Series A
Apr 29, 2024
Total Funding Raised
$20.86M
Company Overview
Adaptilens is a medical device company that develops an innovative intraocular lens that mimics the natural human lens, providing patients with clear vision at all distances and reducing their reliance on glasses and contact lenses.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptilens Comparables
Compare Adaptilens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LensGen | 90% | |
| JelliSee Ophthalmics Inc. | 90% | |
| Atia Vision | 89% |
Adaptilens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 29, 2024 | ||||
| Grant | May 5, 2022 | ||||
| Grant | Jun 14, 2021 | ||||
| Seed | Nov 12, 2020 | ||||
| Seed | Aug 5, 2020 |
Key People
Founding team and executive leadership
Adaptilens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Massachusetts Life Sciences Center | Grant |
| Pillar VC | Series A, Seed |
| Accanto Partners | Seed, Series A |
| 380 Cap | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2020
$1.6M round led by Pillar VC
Adaptilens Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adaptilens's valuation, stock price, and market status.
Is Adaptilens a public or private company?
Adaptilens is a private company.
What is the current stock price of Adaptilens?
Adaptilens is a private company with no public stock price. No recent secondary market data is available.
How much is Adaptilens worth (valuation)?
Valuation information for Adaptilens is not publicly available.
Can I buy Adaptilens stock?
Adaptilens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Adaptilens's last funding round?
Adaptilens's most recent funding round was Series A on April 29, 2024.
Who are the main investors in Adaptilens?
Key investors in Adaptilens include Pillar VC.
Will Adaptilens IPO soon?
No public IPO plans have been announced for Adaptilens.
How can I track Adaptilens secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adaptilens's secondary market activity and sign up for updates.